Skip to main content Help with accessibility Skip to main navigation

High Cost Drugs

Here you will find the Funding Position of CCG Commissioned High-Cost Drugs within the Lancashire and South Cumbria Health Economy

A number of High-Cost Drugs, devices, procedures and products have been excluded from the scope of the national tariff of Payment by Results. These are listed on tab 18 of the following document:

Annex A:2019/20 Nation Prices And Nation Tariff Workbook

High-cost drugs are commissioned by:

  • NHS England or

  • Clinical Commissioning Groups

The funding position of medicines directly commissioned by NHS England can be accessed via the NHS England website

Refer to the Manual for Prescribed Specialised Services for further information about prescribed specialised services, some of which are directly commissioned by NHS England and some by CCGs.

 

Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Pending
Pending
Red
Pending
Red
Red
Red
Pending
Date Posted: 01 - May - 2014
BNF chapter: Blood and Nutrition
Approval Mechanism: Group Approval
Red
Pending
Pending
Red
Pending
Red
Red
Red
Pending
Date Posted: 01 - Mar - 2014
BNF chapter: Blood and Nutrition
Approval Mechanism: Group Approval
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 01 - Nov - 2018
BNF chapter: Blood and Nutrition
Approval Mechanism: Blueteq